MARKET

AYTU

AYTU

Aytu Biopharma Inc
NASDAQ
2.030
-0.020
-0.98%
Opening 09:33 10/07 EDT
OPEN
2.040
PREV CLOSE
2.050
HIGH
2.040
LOW
2.030
VOLUME
497
TURNOVER
--
52 WEEK HIGH
3.065
52 WEEK LOW
1.800
MARKET CAP
22.06M
P/E (TTM)
-1.7547
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AYTU last week (0928-1002)?
Weekly Report · 2d ago
Microsoft To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Benzinga · 09/30 12:22
Aytu BioPharma Price Target Raised to $15.00/Share From $14.50 by Ascendiant Capital
Dow Jones · 09/30 10:06
Aytu BioPharma Is Maintained at Buy by Ascendiant Capital
Dow Jones · 09/30 10:06
Ascendiant Capital Maintains Buy on Aytu BioPharma, Raises Price Target to $15
Benzinga · 09/30 09:56
Aytu BioScience Earnings Call Highlights EXXUA Momentum
TipRanks · 09/29 00:10
Weekly Report: what happened at AYTU last week (0921-0925)?
Weekly Report · 09/28 09:27
Analysts Offer Insights on Healthcare Companies: Aytu BioScience (AYTU), Surrozen (SRZN) and aTyr Pharma (ATYR)
TipRanks · 09/24 15:21
More
About AYTU
Aytu BioPharma, Inc. is a pharmaceutical company focused on advancing medicines for complex central nervous system (CNS) diseases. Its business is focused on the launch of EXXUA and its prescription pharmaceutical products sold primarily through third-party wholesalers and pharmacies and which primarily consists of two product portfolios. Its Attention Deficit Hyperactivity Disorder (ADHD) portfolio consists of Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) , Cotempla XR-ODT, and METADATE CD, which are CNS stimulants indicated for the treatment of ADHD in patients. Its Pediatric portfolio consists of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine indicated to treat various allergic conditions including seasonal and perennial allergic rhinitis, vasomotor rhinitis, Poly-Vi-Flor, and Tri-Vi-Flor. EXXUA is indicated to treat depressive disorder (MDD) in adults.

Webull offers Aytu Biopharma Inc stock information, including NASDAQ: AYTU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AYTU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AYTU stock methods without spending real money on the virtual paper trading platform.